Cargando…

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Tdap Vaccine: Randomized Phase IIIb Trial in Healthy Participants 9–60 Years of Age in the Philippines

Incorporating dengue vaccination into existing childhood vaccination programs could increase vaccine coverage. This study assessed the safety and immunogenicity of concomitant versus sequential administration of the combined tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Jaime, Montellano, May Emmeline, Solante, Rontgene, Perreras, Nicole, Meyer, Stéphanie, Toh, Myew-Ling, Zocchetti, Céline, Vigne, Claire, Mascareñas, Cesar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Vaccine Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357045/ https://www.ncbi.nlm.nih.gov/pubmed/34117198 http://dx.doi.org/10.1097/INF.0000000000003220

Ejemplares similares

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Quadrivalent Human Papillomavirus Vaccine in Boys and Girls 9–13 Years of Age in Malaysia: A Phase IIIb, Randomized, Open-label Study
por: Hassan, Jamiyah, et al.
Publicado: (2021)

Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia
por: Reynales, Humberto, et al.
Publicado: (2020)

Improving Tdap maternal immunization rate in Saudi Arabia
por: Aldoosari, Agariad, et al.
Publicado: (2023)

An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life
por: Patel, Sanjay S., et al.
Publicado: (2023)

Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
por: Riddle, Mark S., et al.
Publicado: (2016)

Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand
por: Sanchez, Leilani, et al.
Publicado: (2023)

Tdap vaccination in pregnancy
por: Dalcin, Daniel, et al.
Publicado: (2021)

Vaccine attributes and vaccine uptake in Hungary: evidence from a conjoint experiment
por: Thompson, Jack, et al.
Publicado: (2023)

The politics of vaccine hesitancy in Europe
por: Stoeckel, Florian, et al.
Publicado: (2022)

COVID-19 vaccination and changes in preventive behaviours: findings from the 2021 vaccine roll-out in Switzerland
por: Hitchman, Sara C, et al.
Publicado: (2023)

Attitudes towards COVID-19 vaccination and intention to get vaccinated in Western Balkans: cross-sectional survey
por: Jeremic Stojkovic, Vida, et al.
Publicado: (2023)

Consumption and tax gains attributable to Covid-19 vaccinations in 12 EU countries with low vaccination rates
por: Cylus, Jonathan, et al.
Publicado: (2023)

The far-right and anti-vaccine attitudes: lessons from Spain’s mass COVID-19 vaccine roll-out
por: Serrano-Alarcón, Manuel, et al.
Publicado: (2023)

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
por: Sun, Dapeng, et al.
Publicado: (2023)

Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap
por: Gray, Glenda E., et al.
Publicado: (2016)

Explaining the gender gap in COVID-19 vaccination attitudes
por: Toshkov, Dimiter
Publicado: (2023)

Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines
por: Tejedor, Juan Carlos, et al.
Publicado: (2016)

Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization
por: Maxfield, Lori F., et al.
Publicado: (2015)

Vaccination barriers and drivers in Romania: a focused ethnographic study
por: Dube, Eve, et al.
Publicado: (2022)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Measles outbreak in Romania: understanding factors related to suboptimal vaccination uptake
por: Habersaat, Katrine Bach, et al.
Publicado: (2020)

Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development
por: Brehony, Carina, et al.
Publicado: (2014)

Les vaccins dans la prévention des infections associées aux soins
por: Gagneux-Brunon, A., et al.
Publicado: (2017)

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
por: Dunning, Andrew J., et al.
Publicado: (2016)

GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis
por: King, Thomas H., et al.
Publicado: (2017)

‘I’m not an anti-vaxer!’—vaccine hesitancy among physicians: a qualitative study
por: Ecker, Franziska, et al.
Publicado: (2021)

Countering vaccine hesitancy: a systematic review of interventions to strengthen healthcare professionals’ action
por: Lo Moro, Giuseppina, et al.
Publicado: (2023)

Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults
por: Pitisuttithum, Punnee, et al.
Publicado: (2016)

Piliation of Invasive Streptococcus pneumoniae Isolates in the Era before Pneumococcal Conjugate Vaccine Introduction in Malawi
por: Kulohoma, Benard W., et al.
Publicado: (2013)

Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
por: Urakami, Akane, et al.
Publicado: (2017)

Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
por: Karnasuta, Chitraporn, et al.
Publicado: (2017)

The Dutch influenza vaccination policy and medication use, outpatient visits, hospitalization and mortality at age 65
por: Van Ourti, Tom, et al.
Publicado: (2020)

Association between Covid-19 sources of information, beliefs, and vaccination rates: an EU-wide survey
por: De la Cruz-Sánchez, Ernesto, et al.
Publicado: (2023)

Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein
por: Cimica, Velasco, et al.
Publicado: (2016)

Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms
por: McCraw, Dustin M., et al.
Publicado: (2016)

Characterization and Vaccine Potential of Membrane Vesicles Produced by Francisella noatunensis subsp. orientalis in an Adult Zebrafish Model
por: Lagos, Leidy, et al.
Publicado: (2017)

B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine
por: Ramani, Sasirekha, et al.
Publicado: (2017)

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
por: Alves, Eduardo, et al.
Publicado: (2017)

IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
por: Karasavvas, Nicos, et al.
Publicado: (2015)

Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
por: Galgani, Ilaria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dcetb84uj9ic7pp0imcr8rp601